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Background: Routine outcome monitoring (ROM) may enhance individual treatment and is also
advocated as a means to compare the outcome of different treatment programs or providers.
There is debate on the optimal instruments to be used for these separate tasks.
Methods: Three sets with longitudinal data from ROMwere analyzed with correlational analysis
and repeated measures ANOVAs, allowing for a head-to-head comparison of measures regarding
their sensitivity to detect change. The responsiveness of three disorder-specific instruments, the
Beck Depression Inventory, the Inventory of Depressive Symptoms, and the Mood and Anxiety
Symptoms Questionnaire, was compared to three generic instruments, the Symptom Checklist
(SCL-90), the OutcomeQuestionnaire (OQ-45), and the Brief Symptom Inventory, respectively.
Results: In two of the three datasets, disorder-specificmeasuresweremore responsive compared
to the total scoreongeneric instruments. Subscale scores fordepressionembeddedwithin generic
instruments are second best and almost match disorder-specific scales in responsiveness. No evi-
dence of a desynchronous response on outcomemeasures was found.
Limitations: The present study compares measures head-to-had, and responsiveness is not
assessed against an external criterion, such as clinical recovery.
Discussion: Disorder-specific measures yield the most precise assessment for individual treat-
ment and are recommended for clinical use. Generic measures may allow for comparisons across
diagnostic groups and their embedded subscales approach the responsivenessof disorder-specific
measures.
K EYWORDS
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1 INTRODUCTION
There is evidence that routine outcome monitoring (ROM) has a pos-
itive influence on treatment efficacy (Lambert, 2010) and efficiency
(Delgadillo et al., 2017) in mental health care. Routine measurements
can beused in individual treatments by clinicians andpatients to deter-
mine progress and the necessity to adapt interventions (Van, Dekker,
Peen, van Aalst, & Schoevers, 2008), but they may also be used to
evaluate the overall effectiveness of treatment programs, both within
the same patient group as across diagnoses. The second goal could
also include benchmarking, comparing outcomes of different teams or
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
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providers, in order to learn from each other and to improve treatment
modalities (Barendregt, 2015). In the Netherlands, ROM has been
implemented in mental healthcare with the aim to improve outcomes
on the level of individual treatments as well as on the level of teams
or providers (de Beurs, Barendregt, &Warmerdam, 2017). In terms of
instruments, there is debate on whether the same instrument can be
used for bothgoals, andwhichgoal shouldbeprioritizedwhen timeand
effort are limited (Meesters, Duijzer, Nolen, Schoevers, & Ruhé, 2016).
Among measures to assess treatment outcome of depression,
a distinction can be made between disorder-specific instruments,
such as the Beck Depression Inventory (BDI) or the Inventory of
Depress Anxiety. 2019;36:93–102. wileyonlinelibrary.com/journal/da 93
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Depressive Symptomatology (IDS), and generic instruments for gen-
eral psychopathology, such as the Outcome Questionnaire (OQ-45;
Lambert, Gregersen, & Burlingame, 2004) or the Symptom Check-
list/Brief Symptom Inventory (SCL-90/BSI; Derogatis, 1975a, 1975b).
Advantage of generic instruments is that they allow for a comparison
of treatment outcomes across diagnoses. Furthermore, they are con-
venient for use in everyday clinical practice, as the same instrument
can be used to assess all patients. However, generic instruments may
be less informative regarding specific symptoms of depression and
less responsive to change as compared to instruments specifically
designed to assess the severity of depression (Meesters et al., 2016).
The literature on the comparative responsiveness of generic and
disorder-specific measures is expansive, but results are far from
conclusive (Beaton, Bombardier, Katz, & Wright, 2001; Husted,
Cook, Farewell, & Gladman, 2000; Terwee et al., 2007). Some studies
report greater responsiveness of disorder-specific measures (Husted
et al., 2000; Reine et al., 2005; Wiebe, Guyatt, Weaver, Matijevic, &
Sidwell, 2003); others do not find a difference (Ades, Lu, & Madan,
2013; McCrindle et al., 2014; Tu, Hwang, Hsu, & Ma, 2017). The
findings depend on the measures that are compared, the concepts
assessed (e.g., quality of life vs. symptoms), the patient population
under investigation, and the statistical approach chosen to investigate
responsiveness (Terwee, Dekker, Wiersinga, Prummel, & Bossuyt,
2003). Several studies compare generic and disorder-specific mea-
sures of health-related quality of life (Ades et al., 2013; Wiebe et al.,
2003), but comparisons between measures of clinical symptoms of
mental disorders are less common (Hansson, Chotai, Nordstöm, &
Bodlund, 2009;Wahl et al., 2014).
In psychiatry, research comparing responsiveness of generic and
disorder-specific instruments for the assessment of the severity of
psychopathology, is rather scarce. Most research compares quality
of life measures, such as the EQ-5D and the SF-36 (Brazier et al.,
2014), or is limited to cross-sectional analysis (Mauriño, Cordero, &
Ballesteros, 2012). In the Netherlands, a study with eating disorder
patients found superior responsiveness for the disorder-specific Eat-
ing Disorders Examination Questionnaire (EDE-Q; Fairburn & Beglin,
2008) over the generic BSI. The pre-to-posttest change was substan-
tially larger on the EDE-Q (ESEDE-Q = 0.84) than on the BSI (ESBSI =
0.45). According to the BSI, 54.2% of the patients had improved or
recovered according to the EDE-Q compared to 45.3% (Dingemans &
van Furth, 2017). Recently, van der Mheen and colleagues compared
various disorder-specificmeasures for anxietywith the genericOQ-45
and BSI and found superior responsiveness for disorder-specific mea-
sures as compared to the OQ-45 total score, but not compared to the
BSI total score (van derMheen, terMors, van denHout, & Cath, 2018).
Responsiveness can be investigated by comparing results of differ-
ent studies using distinct measures (Kounali, Button, Lewis, & Ades,
2016), but a stronger design is a “head-to-head” comparison of instru-
ment in the same study (Wiebe et al., 2003). Responsiveness is inves-
tigated with correlational analyses or by comparing effect sizes (ES)
of pre-to-posttest change according to various outcome measures (de
Beurs et al., 2012;Hustedet al., 2000). Responsiveness is best assessed
and compared by investigating the course of scores over time of mea-
sures from the same longitudinal dataset. Although two assessments
suffice to detect a difference in responsiveness, additional assess-
ments allow for a more fine-grained analysis, for instance, detecting
desynchrony of response over time (patients may change first on one
measure and in a later phase of their treatment on another measure).
For an ongoing benchmark project in the Netherlands by
Stichting Benchmark GGZ, the use of generic outcome scales is
prescribed, such as the BSI (Derogatis, 1975a), the OQ-45 (Lambert
et al., 2004), and the recently developed Dutch Symptoms
Questionnaire-48 (Carlier et al., 2012; Carlier et al., 2017), to assess
the outcome of treatment of psychiatric patients. However, a debate
arose about the suitability of generic outcome scales (Meesters et al.,
2016), as disorder-specific instruments, such as the BDI (Beck & Steer,
1990), the Inventory of Depressive Symptoms Self-report (IDS-SR;
Rush, Gullion, Basco, Jarrett, & Trivedi, 1996), and the Mood and
Anxiety Symptoms Questionnaire (MASQ; Watson et al., 1995), are
possibly more responsive. Consequently, changes in symptomatology
within patients may go unnoticed and wemight get a too conservative
estimate of the benefits of mental health care. Also, differences in
performance between various providers may remain obscured when
relatively unresponsive outcomemeasures are used.
In this paper, we report on three comparisons of generic and
disorder-specific measures for depression in three separate datasets.
Wecompared (1) BDIwith SCL-90, (2) IDS-SRwithOQ-45, and (3) BDI,
MASQ, and BSI. We compared total scores on these instruments, but
also subscale scores. Our hypothesis is that responsiveness improves
with increased specificity for depression of the (sub)scale.Wewill also
explore the data for signs of desynchrony in change over time between
(sub)scales of the investigated instruments, as disorder-specific scales
may detect change at an earlier phase of treatment than generic ones.
2 METHODS
2.1 Source of the data
Two datasets stem from the University Center Psychiatry (UCP) of the
UniversityMedical Center Groningen (UMCG), theNetherlands, a ter-
tiary center for the treatment of mood, anxiety, and somatoform dis-
orders. UCP provided data for the comparison of the BDI with the
SCL-90 (collected from January 2012 until May 2016) and the IDS-
SR with the OQ-45 (collected from September 2012 until May 2016).
TheDepartment of Psychiatry of the LeidenUniversityMedical Center
(LUMC;CentrumOnderzoekRoutineOutcomeMonitoring [COROM])
and the Mental Health Care Institute GGZ-Rivierduinen, providing
secondary mental health care in the densely populated west of the
country, yielded data for the BDI, MASQ, and BSI comparison (col-
lected from April 2002 until October 2011). All patients from Leiden
were diagnosed with the Mini International Neuropsychiatric Inter-
viewPlus, a structured diagnostic interview (MINI-plus; Sheehan et al.,
1998; van Vliet & de Beurs, 2007). In Groningen, diagnoses (DSM IV)
were determined in an intake session by a clinician.
All data were collected by ROM (de Beurs et al., 2011). Patients
in ambulatory care, mostly seen weekly for psychological treatment
and/or pharmacological treatment, were assessed at fixed intervals
during their treatment, usually every3 to4months. As treatments vary
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in duration, the number of assessments per patient varies as well. Data
of instruments werematched on ID of the respondent and assessment
moment (a match was declared when the assessment of the instru-
ments had taken place in the sameweek,whichwas usually at the same
occasion). The first dataset yielded longitudinal data with minimally
two and a maximum of five consecutive assessments (N = 233); the
second and third yielded a maximum of 10 assessments (N = 832 and
N=3,409, respectively). Patients gavepermission for the (anonymized)
use of their data for scientific purposes.
2.2 Measures
2.2.1 Disorder specific
The BDI-II (Beck & Steer, 1990) is a revised version of the original BDI
(Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) and the most com-
monly used self-report instruments to assess the severity of depres-
sion. The questionnaire includes 21 items and each item has a set of
four unique response options (0–3). For the Dutch translation, the
BDI total score (BDI-TOT) and three subscale scores can be com-
puted: the BDI cognitive factor (BDI-COG) with seven items, the BDI
affective factor (BDI-AFF) with five items, and the BDI somatic factor
(BDI-SOM)with nine items (van der Does, 2002).
The IDS-SR (Rush et al., 1996) alsomeasures the severity of depres-
sion and includes 30 items with unique response options on a 4-point
scale. A total score for 28 items (IDS-TOT) and two subscale scores
for mood/cognition (IDS-MOOD) with 11 items and anxiety/arousal
(IDS-ANX) with eight items (Wardenaar et al., 2010).
TheMASQ (Watson et al., 1995) was developed to assess the symp-
toms of depression and anxiety disorders more distinctively. Items
describe symptoms shortly and all have the same five response options
on a Likert scale (not at all to very much). A total score (MASQ-TOT,
90 items) and subscale scores can be calculated for (lack of) positive
affect (MASQ-PA; 22 items and specific for mood disorders), Somatic
Anxiety (MASQ-SA; 18 items and specific for anxiety disorders) and
negative affect (MASQ-NA; 20 items and nonspecific to depression
or anxiety). The factorial structure is replicated in the Dutch transla-
tion of the MASQ by de Beurs, den Hollander-Gijsman, Helmich, and
Zitman (2007).
All these instruments have good psychometric properties, both the
U.S. originals and their Dutch translations (de Beurs et al., 2007; van
der Does, 2002;Wardenaar et al., 2010).
2.2.2 Generic specific
The SCL-90 (Derogatis, 1975b) is a generic self-report questionnaire
for the severity of psychopathology (Koeter, Ormel, & van den Brink,
1988). The checklist includes 90 short descriptions of problems or
symptoms, and respondents are asked to indicate howmuch theywere
bothered in the last week on a Likert scale with five response options
(not at all to very much). The total score (SCL-TOT) is the sum of all
responseswith a range of 90–450. TheDutch translation has goodpsy-
chometric properties (Arrindell & Ettema, 1986), but uses a different
dimensional structure than the U.S. original with eight subscales: anx-
iety, agoraphobia, depression (SCL-DEP), somatization, insufficiency
in thinking or behavior (SCL-IN), interpersonal sensitivity, hostility
(SCL-HOS), and sleeping problems.
The BSI (Derogatis, 1975a) is a shortened version of the SCL-90
with 53 items with identical instructions and response options. The
total score on the 53 items is the BSI-TOT and is calculated as the
mean score on all items with a range of 0–4. The Dutch BSI has nine
subscales—in accordance with the U.S. original—of each five to six
items: depression (BSI-DEP), somatization (BSI-SOM), anxiety, phobia,
interpersonal sensitivity, obsessive compulsive, hostility, paranoia, and
psychoticism. The Dutch version of the BSI has good psychometric
properties (de Beurs & Zitman, 2006).
TheOQ-45 (Lambert et al., 2004) has 45 items, asking the patient to
indicate how often a symptom or problem occurred in the week prior
to the assessment on a Likert scale (never–almost always). A total of 25
items describe problems and symptoms and compose the symptomatic
distress scale (OQ-SD, range 0–100); 11 items assess functioning with
family and friends, and compose interpersonal relations scale (OQ-IR,
range 0–44); and nine items assess functioning at work or school, and
compose the social role scale (OQ-SR, range 0–36). Also, a total score
can be computed for general well-being (OQ-TOT, range 0–180). The
Dutch translation has good psychometric properties (de Beurs, den
Hollander-Gijsman, Buwalda, Trijsburg, & Zitman, 2005; de Jong et al.,
2007). On all instruments, higher scores indicate more severe depres-
sion, more symptoms or problems, andworse functioning.
The dichotomy of generic and disorder-specific does not hold when
subscale scores on generic instruments are also taken into considera-
tion. Table 1 shows a proposal on how to place instruments and their
subscales on the dimension generic–depression specific. The OQ-TOT
is deemed the most generic as this score includes functioning as well
as symptomatology. Next, the OQ-SD and the SCL-90/BSI-TOT assess
general symptomatology/psychopathology. The MASQ-TOT is some-
what more specific, assessing only symptoms of mood and anxiety dis-
orders. Negative affect is specific to depression at the same level as the
BDI-TOT and IDS-TOT. Finally, the IDS-SR and BDI-subscales and the
MASQ-PA are deemed to be themost specific for depression.
2.3 Statistical analyses
To put all instruments on a common metric, scores were standardized
on the pretest mean and standard deviation. Consequently, the entire
population gets a baseline score ofM = 0 (SD = 1) on all scales. Scores
diminish over time and the absolute value of mean score at consecu-
tive assessments represents the within groups effect size (ES) for each
(sub)scale. We established the ES for the first and second assessment
(initial treatment phase) and for the first and last available (nth) assess-
ment (themaximum pre-to-posttest change).
In each dataset, the correlations between (sub)scales of instru-
ments at baseline and at the last available assessment were calculated,
Furthermore, the correlations between difference scores for the first
assessment interval and for the maximum interval (first to nth assess-
ment) were calculated. High correlations between differences scores
suggest similar responsiveness.
Responsiveness was also investigated with repeated measures
ANOVAs on subsets of the three sampleswith complete data for three,
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TABLE 1 Position of total scale scores and subscale scores of the instruments on the dimension from generic to disorder-specific
Dimension:
Scale: Generic Specific
OQ OQ-TOT OQ-SD IDS-TOT IDS-MOOD
BDI BDI-TOT BDI-AFF/COG
MASQ MASQ-TOT MASQ-NA MASQ-PA
SCL/BSI SCL/BSI-TOT SCL/BSI-DEP
Notes. OQ-TOT, OQ-45 total score; OQ-SD, symptomatic distress; OQ-IR, interpersonal relations; IDS-TOT, IDS-SR total score; IDS-MOOD, mood symp-
toms; BDI-TOT, BDI total score; BDI-AFF, affective factor; BDI-COG, cognitive factor; SCL/BSI-TOT, SCL-90 or BSI total score; SCL/BSI-DEP, SCL-90 or BSI
depression;MASQ-TOT,MASQ total score;MASQ-NA, negative affect; MASQ-PA, (lack of) positive affect.
four, or five assessments. For instance, as the first dataset yielded suffi-
cient subjectswith at least three assessments, we compared their total
score on the SCL-90 with their total score on the BDI with a repeated
measures ANOVA in a 2 (instrument) × 3 (time) factorial design (see
Table 3); in a similar vein, we compared the SCL-90 depression sub-
scale score with the BDI-TOT. These two ANOVAs were repeated
for the maximum treatment effect in a 2 (instrument) × 2 (time; the
first and the nth assessment) design. All analyses yield a time effect
(scores changeover time irrespectiveof the instrument), an instrument
effect (standardized scores differ between instruments irrespective of
time), and a time-by-instrument interaction. This interaction effect is
most informative, as it signifies a difference in responsiveness between
instruments: the score on instrument A decreases more over time (or
sooner in time) than the score on instrument B. The analyses yield an
F-statistic, P-value, and effect size indicator (𝜂2) for each effect. As the
size of the datasets yields ample power to find statistically significant
differences over time or between measures, the ES of the ANOVAs
are most informative; 𝜂2 can be interpreted as the amount of vari-
ance explained and—according to the rule of thumb of Cohen (1988)—
𝜂2 = 0.020 is a small effect, 𝜂2 = 0.130 is an intermediate effect, and
𝜂2 = 0.260 is a large effect.
3 RESULTS
3.1 The three datasets
In the dataset for the comparison of the BDI and the SCL-90 (N= 233),
themean age of respondentswasM=33.7 years (SD=11.1) and52.8%
was female. All patients suffered from a mood disorder, although this
was not for all the primary diagnosis. According to their primary diag-
nosis, 29.6% of patients had a mood disorder (major depressive dis-
order or dysthymia), 34.8% had a somatoform disorder, 18.5% had an
anxiety disorder, and 17.2%had another diagnosis. In the dataset com-
paring the IDS-SR and the OQ-45 (N = 832), mean age of patients
wasM = 38.4 years (SD = 13.7) and 54.9% was female; here, 60.3% of
patients had a primary diagnosis of mood disorder, 27.1% had an anx-
iety disorder, 3.7% had a somatoform disorder, and 8.9% had another
primary diagnosis. Both datasets comprised patients from the UCP of
the UMCG and represent patients typically seen in an outpatient clinic
for common mental disorders. In the third dataset, stemming from
Leiden, the BSI–BDI-MASQ dataset (N = 3409), the mean age of
patients was M = 40.7 years (SD = 13.4) and 64.0% was female. All
patientswere referred for treatment formood, anxiety, or somatoform
disorder and all were diagnosed with the MINI-plus (Sheehan et al.,
1998). Here, no distinction was made between primary and secondary
disorders. A total of 2,370 patients (69.5%) met criteria of a (single or
comorbid) mood disorder; 340 (10.0%) had an anxiety, or somatoform
disorderwithout a comorbid depression; 699 (20.5%) did notmeet for-
mal criteria for a current mood, anxiety, or somatoform disorder. In all
three datasets, data were reanalyzed in a pure subset of patients with
a primarymooddisorder diagnosis (n=69 and502) or amooddisorder
according to theMINI-plus (n= 2,370).
Table 2 presents the number of patients per assessment and the
average assessment interval. The mean length of the total assessment
interval wasM= 371 days (SD= 183) for the BDI–SCL-90 comparison,
M = 394 days (SD = 282) for the IDS–OQ-45 pair, and M = 315 days
(SD= 250) for the BSI–BDI-MASQ comparison.
3.2 Comparison of BDI and SCL-90
Supporting Information Table A shows Pearson correlation coeffi-
cients between BDI and SCL-90 (sub)scales at baseline, at the last
assessment, and for the difference score for the first assessment inter-
val (and for the maximal difference score, the first to nth assessment).
The correlations are of medium or high size (>0.70); correlations
between the BDI-TOT, the SCL-TOT, and the SCL-DEP are the highest.
This applies to the cross-sectional correlations, but also for the lon-
gitudinal difference scores. At first glance, these scales measure the
same concept, and difference scores are also substantially associated
(Supporting Information Table B).
Figure 1 (left) shows the maximum ES for the (sub)scales of the
BDI and the SCL-90, ordered from high to low. The BDI-TOT and BDI-
COG are the most responsive (ESBDI-TOT = 0.96 and ESBDI-COG = 0.91);
the SCL-TOT is less responsive (ESSCL-TOT = 0.75); and the SCL-
DEP is somewhat more responsive (ESSCL-DEP = 0.82). Other sub-
scales of the SCL-90 are again less responsive (ESSCL-ANG = 0.62 and
ESSCL-HOS = 0.37).
For this dataset, 160 patients had complete data at three assess-
ments and their datawere analyzedwith repeatedmeasures ANOVAs.
The results are presented in Table 3 and show a large time effect
(𝜂2 = 0.413). Irrespective of the instrument, scores diminish and
patients improve. There is also a small to intermediate instrument
effect and a small to intermediate interaction effect: the responsive-
ness of instruments differs. The results in the Supporting Information
Table B, which displays more detailed information on the significant
effects using a repeated time and a simple instrument contrast in the
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TABLE 2 Number of patients and length of time intervals in days for the full samples and for the "depression-only" subsamples
BDI and SCL-90 First and second Third Fourth Fifth assessment
N 233 160 48 6
Interval:M (SD) 146.5 (62.8) 243.8 (121.8) 253.7 (71.4) 195.8 (80.6)
Subset with depression only
N 69 52 23 1
Interval:M (SD) 151.0 (43.7) 202.7 (97.1) 268.7 (58.6) 76.0
IDS-SR andOQ-45
N 832 402 210 107
Interval:M (SD) 222.8 (191.2) 168.5 (134.0) 165.9 (122.3) 194.5 (150.2)
Subset with depression only
N 502 238 132 79
Interval:M (SD) 204.5 (179.4) 168.4 (141.2) 158.1 (123.9) 198.2 (145.1)
BDI, BSI, andMASQ
N 3409 1804 943 479
Interval:M (SD) 149.0 (63.4) 140.9 (60.5) 141.0 (59.0) 147.9 (61.7)
Subset with depression only
N 2370 1311 705 370
Interval:M (SD) 150.7 (64.8) 140.5 (60.9) 141.5 (58.3) 146.8 (60.8)
Notes. BDI, beck depression inventory; SCL-90, symptom checklist; IDS-SR, inventory of depressive symptoms self-report; OQ-45, outcome questionnaire;
BSI, brief symptom inventory;MASQ, mood and anxiety symptoms questionnaire.
F IGURE 1 Responsiveness (standardized ES) of (sub)scales in the three datasets: the SCL-90 and BDI scales (left), the IDS-SR and OQ-45 (mid-
dle), and the BSI, MASQ, and BDI scales (right), rank ordered by size
TABLE 3 Overview of results of repeatedmeasures ANOVAs for various comparisons of BDI and SCL (sub)scales
Time Instrument Time× Instrument2
Comparison N df F 𝜼2 df F 𝜼2 df F 𝜼2
BDI vs. SCL-TOT First, second, and third 160 2,318 111.64 0.413 1,159 28.19 0.151 2,318 14.54 0.087
BDI vs. SCL-DEP First, second, and third 160 2,318 93.69 0.397 1,159 18.94 0.011 2,318 9.47 0.056
BDI vs. SCL-TOT First vs. nth 233 1,232 181.50 0.439 1,232 12.15 0.050 1,232 20.44 0.081
BDI vs. SCL-DEP First vs. nth 233 1,232 178.77 0.435 1,232 7.89 0.033 1,232 7.49 0.031
Notes. BDI, BDI total score; SCL-TOT, SCL-90 total score; SCL-DEP, SCL-90Depression subscale; statistically significantmain and interactioneffects (P<0.05)
are indicated by 𝜂2 in bold typeface.
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F IGURE 2 Course over time of standardized scores on the SCL90 and BDI for the group with three assessments (n = 160); on the IDS and OQ
for the subgroupwith four assessments (n= 210), and on the BDI, BSI, andMASQ for the groupwith five assessments (n= 479)
ANOVAs, show that the time effect is the largest in the initial phase of
the treatment (𝜂2 = 0.442. vs. 𝜂2 = 0.023 for the first and the second
phase of the treatment, respectively). Furthermore, the instrument
contrast (a simple contrast comparing the BDI-COG with the other
scales) reveals that the BDI-COG factor is more responsive than most
of the SCL-90 subscales except for the SCL-DEP and SCL-IN scales. A
further distinction by therapy phase indicates that the instrument-by-
time interactions are only significant in the first phase (again except
for the SCL-DEP and SCL-IN). The course of scores over time is shown
in Figure 2 (left). It illustrates that the BDI-TOT is the most responsive
scale.
3.3 Comparison of IDS-SR andOQ-45
Supporting Information Table C presents Pearson correlation coeffi-
cient between the IDS-SR and theOQ-45 and their subscales. The cor-
relation between the IDS-SR scales and the OQ-45 OQ-SD are high;
correlations are lower between the IDS-SR and the functioning scales
of theOQ-45 (OQ-SR andOQ-IR).
Figure 1 (middle) shows the maximum ES values from N = 832
respondents. The OQ-SD has the largest pre–post difference
(ESOQ-SD = 0.55), followed by the OQ-TOT, the IDS-TOT, and the
OQ-SR (ES OQ-SR = 0.48). TheOQ-IR is less responsive.
A subset of these data was analyzed with repeated measures
ANOVAs. As Table 4 shows, only the analyses comparing subscales of
the instruments yield a significant (but small) interaction effect. The
contrasts in Supporting Information Table D show that also in this
dataset, the largest decrease in scores occurs in the first months of
treatment (𝜂2 = 0.121, 0.055, and 0.029 in the first three phases of
treatment). The only significant interaction effect is the difference in
responsiveness between the IDS-MOOD and the OQ-IR subscale dur-
ing the second treatment phase (𝜂2 = 0.24).
The course of scores over at least four assessments is depicted
in Figure 2 (middle). Four subscales indicate a similar decline over
time: IDS-TOT, OQ-SD, OQ-TOT, and OQ-SR (ES ranges from 0.62
to 0.69). Again, the OQ-IR is less responsive to change, with
ESOQ-IR = 0.42.
3.4 Comparison of BDI,MASQ, and BSI
Supporting Information Table E presents correlation coefficients
between the BDI and the BSI; Supporting Information Table F shows
correlation coefficients between the BDI and MASQ and the BSI and
MASQ. Scalesmeasuring corresponding constructs correlate consider-
ably, both cross-sectionally and longitudinally (difference scores). This
holds for depression, but also for somatic anxiety (the MASQ-SA) and
somatic symptoms (the BSI-SOM). Lack of positive affect of theMASQ
(supposedly the hallmark of depression; cf. Clark, Watson, & Mineka,
1994) is less strongly correlated with depression according to the BDI
or the BSI-DEP score. Figure 1 (right) shows maximum ES for the total
scores and subscale scores of the BDI, MASQ, and BSI. The positive
affect scale (the subscale of theMASQspecific for depression) appears
the most responsive (ESMASQ-PA = 1.02); the BDI-TOT, BDI-SOM, BDI-
AFF, MASQ-TOT, and the BSI-DEP (ESBSI-DEP = 0.79) are all still fairly
responsive. The BSI subscales not assessing depression are the least
responsive (ESBSI-SOM = 0.40).
Table 5 shows the results of repeated measures ANOVAs. The
scores of five assessments were used. There were significant differ-
ences in responsiveness between total and subscale scores (small to
intermediate 𝜂2), which is illustrated in Figure 1 (right): the MASQ-PA
and the BDI-TOT scale were the most responsive (ESMASQ-PA = 1.02
and ESBDI-TOT = 0.92); the BSI-DEP and the BSI-TOT were less respon-
sive (ESBSI-DEP = 0.79 and ESBSI-TOT = 0.71). Almost all time and
instrument contrasts are statistically significant. ES (𝜂2) in Supporting
Information Table G reveals that the largest differences in respon-
siveness are between the BDI-TOT (the most responsive scale in this
dataset) and the BSI and MASQ subscales not measuring depression
(e.g., MASQ-SA). The course over time is illustrated in Figure 2 (right).
Finally, all analyses were repeated for more homogenous diagnos-
tic groups of only patients diagnosed with depression and patients
diagnosed with singular depression (without comorbid conditions).
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TABLE 4 Overview of results of repeatedmeasures ANOVA of various comparisons of IDS andOQ-45 (sub)scales
Time Instrument Time× instrument
Comparison N df F 𝜼2 df F 𝜼2 df F 𝜼2
IDS vs. OQ-TOT First, second, third, and fourth 210 3,627 42.34 0.168 1,209 0.09 0.004 3,627 0.53 0.003
IDS vs. OQ-SD First, second, third, and fourth 210 3,627 40.98 0.164 1,209 0.11 0.001 3,627 1.19 0.006
IDS vs. OQ-TOT First vs. nth 832 1,831 252.10 0.233 1,831 1.05 0.001 1,831 0.02 0.000
IDS vs. OQ-SD First vs. nth 832 1,831 254.08 0.234 1,831 1.78 0.003 1,831 1.81 0.002
Notes. IDS, IDS-SR total score; OQ-TOT, total score; OQ-subs, OQ-45 subscales; OQ-SD, symptomatic distress subscale; statistically significant main and
interaction effects (P< 0.05) are indicated by 𝜂2 in bold typeface.
TABLE 5 Overview of results of repeatedmeasures ANOVA of various comparisons of BDI, MASQ, and BSI (subscales)
Time Instrument Time× instrument
N df F 𝜼2 df F 𝜼2 df F 𝜼2
TOT scales First to Fifth 479 4,1912 123.87 0.206 2,1912 37.81 0.073 8,3824 11.87 0.024
BDI, PA, BSI-DEP First to Fifth 479 4,1912 109.42 0.186 2,956 0.77 0.002 8,3824 3.79 0.008
TOT scales First vs. nth 3,409 1,3408 2470.88 0.420 2,3408 128.70 0.036 2,6816 262.19 0.071
BDI, PA, BSI-DEP First vs. nth 3409 2,3408 2460.64 0.419 2,6816 82.84 0.024 2,6816 166.74 0.047
Notes. TOT-scales, total score on BDI, MASQ, and BSI; BDI, BDI-total score; PA,MASQ-positive affect; BSI-DEP, BSI-depression.
By and large, the findings of these analysis regarding the comparative
responsiveness of the instruments mimicked the results found with
the entire sample, as reported in Table 5 and Supporting Information
Tables E, F, and G. Correlational analyses and ANOVAs with the mood
disorder samples were similar to the earlier findings; the pre-to-
posttest change on scales was somewhat larger in comparison to the
diagnostically more heterogeneous samples (∼0.10 ES points), but the
comparative responsiveness remained the same.
4 DISCUSSION
Correlational analyses revealed a pattern of associations among the
measures and their subscales, which is in line with the concepts they
intend to measure. Associations among (difference) scores between
(sub)scales for the same construct are high and lower for distinct con-
structs. Correlations between difference scores tend to be lower com-
pared to correlations between scores at single assessment occasions,
due to inter-individual variation in change and due to the lower reli-
ability of difference scores. Measurement errors at both time points
limit the reliability of difference scores, which is by definition lower
than the reliability of single scores (Cronbach, 1984). At first glance,
especially the correlational results between difference scores suggest
similar responsiveness of generic anddisorder-specific instruments for
depression.
RepeatedmeasuresANOVArevealeddifferences in responsiveness
in twoof the three datasets in the expected direction: disorder-specific
scales tend to be more responsive than total scores on generic scales,
although the ES of the statistically significant time-by-instrument
effects are small. Generally, no evidence of desynchrony in response
was found. The most responsive scale is the BDI-TOT, but not its sub-
scale scores. The BDI-TOT is 1.3 times more responsive than the SCL-
90 total score in the first dataset and 1.4 times more responsive than
the BSI-total score in the third dataset. Differences between the BDI-
TOT and the depression subscales of the SCL-90 or BSI are somewhat
less pronounced, but the BDI is still 1.2 times more responsive. The
differences in responsiveness between the instruments may be due to
various factors, as their psychometric properties diverge, such as reli-
ability (test–retest and internal consistency, unidimensionality of the
scales, and thenumberof items), properties of items (informationvalue
and scalability), and properties of response formats (generic vs. specif-
ically adapted to the item content, such as the BDI). Finally, the valid-
ity of the scales (how well the scales cover the concept of depression)
is important: depression scales are dedicated to the measurement of
depression, whereas generic scales may miss some relevant aspects of
depression and their total score includes items that are irrelevant to
depression.
According to the ANOVA for repeated measurements, the depres-
sion subscales of the SCL-90 (Table 3 and Supporting Information
Table B) and the BSI (Table 5 and Supporting Information Table G) do
not differ from the most responsive subscale of the BDI in their ability
to detect chance. Thus, our hypothesis that themost specific scaleswill
be themost responsive is not fully confirmed by the results.Within the
generic SCL-90 and BSI, subscales for depression are more responsive
than total scores on these instruments, butwithin the disorder-specific
BDI and IDS, subscales are generally not more responsive than the
total scores. Finally, we see no desynchrony in responsiveness among
the compared (sub)scales.
The three samples in this study were composed of patients with
common mental disorders, predominantly depression, but also some
patients with anxiety or somatoform disorders were included, who did
not meet formal diagnostic criteria for a (comorbid) mood disorder.
The findings should be interpreted with caution as the data were
obtained in everyday clinical practice and stem from a somewhat
heterogeneous sample. Repeating the analyses in the sample, after
removing the patients without a depression diagnosis, did not alter
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the results in a meaningful way. Finally, we reanalyzed the data from
patient with a singular mood disorder (which was only possible in
the Leiden sample with complete diagnostic information). The results
were highly similar to the initial findings, except for lower baseline
scores of patients with a singular mood disorder and a slight increase
in the pre-to-posttest change in the pure depression groups compared
to the more diagnostically mixed samples. Apparently, both in the
purer mood disorder samples as well as in the more heterogeneous
samples, total scores on disorder specific scales are more responsive
than total scores on generic scales. Most items of the BDI or IDS
are relevant for this patient group, whereas in the SCL-90 or BSI,
there are many items with less relevance, lowering the SCL90 or
BSI-TOT at baseline and thus making these scales less responsive to
change.
Surprisingly, the second dataset showed that the IDS-SR total score
and its subscale scores are not more responsive than the OQ-45 or its
subscales. A possible explanation for not finding this expected differ-
ence in responsivenessmay be that in general less change in symptoms
was realized in this sample, comprising relatively treatment-resistant
patients, leaving also less room for distinctive responsiveness of both
instruments. However, subscale scores on the IDS-SR appear even less
responsive compared to subscale scores on the OQ-SD (see Table 4
and Figure 2 [middle]). The IDS was composed by Rush and colleagues
(1986) to cover a broad range of symptoms in order to be more sensi-
tive to change than thegold standard fordepressionassessment at that
time, the Hamilton Depression Rating Scale (HDRS; Hamilton, 1960).
There is a rating scale version tobe completedbya clinician (IDS-C) and
a self-report version (IDS-SF). Indeed, Rush et al. (1996) report supe-
rior responsiveness of the IDS-C over the HDRS. Helmreich and col-
leagues (2011) replicated this finding. However, the IDS-SR seems less
responsive than the IDS-C, as Friedet al. (2016) have shown.Moreover,
they raise doubt on the unidimensionality and measurement invari-
ance over time of the IDS-SR. Finally, Corruble and colleagues (1999)
compared the IDS, the Montgomery-A˚sberg Depression Rating Scale
(Montgomery & Asberg, 1979), and the SCL-90 in psychiatric inpa-
tients and reported equal responsiveness of the IDS-SR and the SCL-
DEP subscale, a finding in line with our current findings. The plea of
Meesters et al. (2016) to replace theOQ-45anduse the IDS-SR instead
for benchmarking in the Netherlands is not supported by the present
findings.
Strength of the present study is that the available data offered a
unique opportunity for a head-to-head comparison of generic and
disorder-specific instruments. A further strength is the size of the
three datasets, providing sufficient data to yield ample statistical
power to find statistically significant differences in responsiveness
between self-report instruments. Furthermore, these data were
collected in real-life clinical practice with diverse samples of psy-
chiatric patients (mild to moderate common mental disorders in
ambulatory care in the Leiden sample and a mix of in- and outpatients
with moderate to severe problems in the samples from Groningen).
Finally, the analyses on three or more assessments allowed us to
investigate not only differences in responsiveness among mea-
sures, but also to check for potential desynchrony in change over
time.
5 LIMITATIONS
Not all possible comparisons between measures were feasible. Unfor-
tunately, a dataset for a head-to-head comparison of the IDS-SR
with the SCL-90 or BSI was not available. The IDS-SR was only com-
pared with the OQ-45, and this subsample showed the lowest ES for
the pre-to-posttest change after four assessments, which limits the
chance of finding differences in responsiveness between instruments
in the first place. Future research should reveal how the IDS-SR and
the BSI depression subscale compare in responsiveness. Furthermore,
this study compared Dutch versions of self-report questionnaires and
we recommend replication of this research with the original versions
in English-speaking samples. Finally, all results and conclusions apply
to the situation that we want optimal information from aggregated
data, for example, when comparing outcomes of patient groups in a
randomized controlled trial or in a naturalistic observational study. For
ROM,where the focus is onmonitoring progress of individual patients,
specific information may be required, and this can best be provided
by the administration of (subscales of) disorder-specific instruments.
A final limitation of our study is that it merely focused on internal
responsiveness or the ability of instruments to measure change over
time. The value of the responsiveness index is dependent on the
actual change achieved, which may diverge per study of per patient
sample, as turned out with our three data sets. In contrast, external
responsiveness attempts to denote responsiveness as the relationship
between change in ameasurement and change in an external standard
(Husted et al., 2000). External responsiveness of an instrument may
be expressed in how well it distinguishes between recovered and
unchanged groups of patients. Future research may also evaluate the
external responsiveness of generic and disorder-specificmental health
measures.However, establishing external responsiveness does require
an external criterion to decide on the clinical status of psychiatric
patients, which is somewhat problematic in commonmental disorders,
where the transition of functional to dysfunctional is usually gradual.
This is in line with a more dimensional approach toward conceptual-
izing psychopathology. Also, alternative views on the structure of psy-
chopathology (Krueger & Markon, 2006; Walton, Ormel, & Krueger,
2011) and other models for the association among psychopathol-
ogy symptoms and symptom clusters, such as network models,
(Borsboom & Cramer, 2013; Fried, Epskamp, Nesse, Tuerlinckx,
& Borsboom, 2016) deserve attention in future development and
research of outcomemeasures for depression treatment.
6 CONCLUSION
In conclusion, the disorder-specific BDI is more responsive compared
to the total score on the generic SCL-90, and BSI and the disorder-
specific IDS does not appear more responsive than the OQ-45. The
responsiveness of the depression subscales of the SCL-90/BSI falls in
between. For an efficient assessment of symptomatology in a sample
with diverse psychiatric disorders, it may be sufficient to administer
a generic instrument, preferably with responsive subscales for spe-
cific problems. However, for optimum power to detect differences in a
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trial or for detailed information on individual patients, use of the more
responsive disorder-specific instruments is recommended.
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